Table 2. Cost calculation.

Treatment strategy	Costs (in €) per year
	1	2	3	4	5	6 +
Primary treatment
MR-TULSA	11 378	1470	279	279	139	139
AS	1676	1 676	707	707	279	421
RARP	11 066	557	279	279	139	139
EBRT	8028	557	279	279	139	139
Clinical progression
Salvage ADT with leuprorelinn for 2 years	1859	1859	139	139	139	139
Permanent salvage ADT with leuprorelin	1859	1859	1859	1859	1859	1859
Salvage radiation + 6 months of leuprorelin	6055	557	279	279	139	139
Salvage RARP		557	279	279	139	139
Salvage MR-TULSA	10 774	1470	279	279	139	139
Metastasis
Enzalutamid + leuprorelin	39 609	39 609	39 609	39 609	39 609	39 609

ADTandrogen deprivation therapyASactive surveillanceBCRbiochemical recurrenceEBRTexternal beam radiation therapyMR-TULSAmagnetic resonance imaging-guided transurethral ablationRARProbot-assisted radical prostatectomy